VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Catania, Italy, November 7-8, 2002
Thursday, November 7, 2002
Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)
09.00 - 09.30
Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)
09.30 - 09.50
Organisation of the health care system in Italy 230 Kb (.ppt)
Franco Splendori (Roma), Maria Grazia Pompa (Roma)
09.50 - 10.00
Discussion and lessons learnt
Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)
10.00 - 10.20
Integrated epidemiological system for acute viral hepatitis (SEIEVA) 599 Kb (.ppt)
Alfonso Mele (Roma)
10.20 - 10.50
Coffee break
10.50 - 11.20
Discussion and lessons learnt
Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)
11.20 - 11.40
Epidemiology of hepatitis B and C in Italy from the eighties until now 272 Kb (.ppt)
Pietro Crovari (Genova)
11.40 - 12.00
Epidemiology of hepatitis A and E in Italy 1,921 Kb (.ppt)
Rosa Cristina Coppola (Cagliari)
12.00 - 12.05
Hepatitis E in Italy 158 Kb (.ppt)
Alessandro Zanetti (Milano)
12.05 - 12.30
Discussion and lessons learnt
12.30 - 12.50
Update on WHO GAVI European Regional Working Group and hepatitis B immunization 970 Kb (.ppt)
Nedret Emiroglu (Denmark)
12.50 - 14.00
Lunch
Chair: Alfonso Mele (Roma) and Peter Grob (Zurich)
14.00 - 14.20
Epidemiology of hepatitis B surface antigen mutants in Italy: role and consequences for vaccination programmes 779 Kb (.ppt)
Alessandro Zanetti (Milano)
14.20 - 14.40
Epidemiology of hepatitis B core/pre-core mutants in Italy 1,430 Kb (.ppt)
Maurizia Brunetto (Pisa)
14.40 - 15.00
Discussion and lessons learnt
15.00 - 15.15
Coffee break
Chair: Alfonso Mele (Roma) and Peter Grob (Zurich)
15.15 - 15.50
Prevention of hepatitis C and residual risk of HCV, HIV, and HBV infection following blood transfusion: results of an Italian study 82 Kb (.ppt)
Alessandro Zanetti (Milano)
15.50 - 16.10
Molecular tracing of HCV: options for control of hospital transmission 177 Kb (.ppt)
Filippo Ansaldi (Trieste), Giancarlo Icardi (Genova)
16.10 - 16.30
Discussion and lessons learnt
16.30 Close of the day and summary by the chairs
Conference dinner
Friday, November 8, 2002
Chair: Paolo Bonanni (Firenze) and Alessandro Zanetti (Milano)
09.00 - 09.20
Epidemiology of hepatitis D in Italy
Mario Rizzetto (Torino)
09.20 - 09.30
Discussion and lessons learnt
Chair: Paolo Bonanni (Firenze) and Alessandro Zanetti (Milano)
09.30 - 10.00
Programme of HBV vaccination targeted to risk groups - Long-term protection after hepatitis B vaccination in a cohort of exposed newborns 49 Kb (.ppt)
Tommaso Stroffolini (Roma), Alfonso Mele (Roma)
10.00 - 10.20
Prevention of hepatitis A during outbreaks and post exposure 275 Kb (.ppt)
Paolo Bonanni (Firenze)
10.20 - 10.40
Discussion and lessons learnt
10.40 - 11.00
Coffee break
11.00 - 11.20
The hepatitis A epidemic in Puglia, Italy: lessons learnt and application of prevention programmes 1,337 Kb (.pdf)
Pier Luigi Lopalco (Bari)
11.20 - 11.40
The new Italian guidelines for the use of hepatitis A vaccine 121 Kb (.ppt)
Elisabetta Franco (Roma)
11.40 - 12.00
Discussion and lessons learnt
12.00 - 13.30
Lunch
Session 6 Evaluation of viral hepatitis prevention and control measures in Italy
Chair: Giuseppe Giammanco (Catania) and Mark Kane (Seattle)
13.30 - 14.00
Evaluation framework of viral hepatitis prevention programmes: examples in Italy - Impact of ten years of universal hepatitis B vaccination programmes 418 Kb (.ppt)
Tommaso Stroffolini (Roma) 99 Kb (.ppt)
Paolo Bonanni (Firenze), Alfonso Mele (Roma)
14.00 - 14.30
Discussion and lessons learnt
Chair: Giuseppe Giammanco (Catania) and Mark Kane (Seattle)
14.30 - 15.00
Presentation of the VHPB meeting conclusions 50 Kb (.ppt)
David FitzSimons (Switzerland)
15.00 - 15.30
Discussions
15.30
Close of the meeting